Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 12

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 12
---
 households?

We will deliver only one Notice or set of our proxy
materials (including a Notice of Special Meeting of Stockholders and Proxy Statement), as applicable, to multiple stockholders sharing
an address unless we have received contrary instructions from one or more of the stockholders. We will promptly deliver a separate Notice
or set of our proxy materials, as applicable, to a stockholder at a shared address to which a single copy of any such document was delivered
upon oral or written request to:

Aethlon Medical, Inc.

Attn: Secretary

11555 Sorrento Valley Road, Suite 203

San Diego, California 92121

Telephone No.: (619) 941-0360

A stockholder may notify us at the above address or
phone number that such stockholder wishes to receive a separate Notice or set of proxy materials, as applicable, in the future. Stockholders
sharing an address may direct to us at the above address or phone number requests for delivery of a single Notice or set of proxy materials,
as applicable, as applicable, if they are receiving multiple copies of such documents.

How can I find out the results of the voting at the Special Meeting?

Preliminary voting results will be announced at the
Special Meeting. In addition, final voting results will be published in a Current Report on Form 8-K that we expect to file within four
business days from the Special Meeting. If final voting results are not available to us in time to file a Current Report on Form 8-K within
four business days from the Special Meeting, we intend to file a Current Report on Form 8-K to publish preliminary results and, within
four business days after the final results are known to us, file an additional Current Report on Form 8-K to publish the final results.

| 6 |

<div align='center'>INFORMATION ABOUT STOCK OWNERSHIP

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information as of April
3, 2025, with respect to the ownership of our common stock, by (i) each person known by us to be the beneficial owner of more than five
percent (5%) of the outstanding shares of each class of our capital stock, (ii) each of our directors and director nominees, (iii) each
of our executive officers, and (iv) all of our named executive officers and directors as a group. As of such date, we had 16,085